Skip to main content

Table 3 Learning needs of hospitals on AMS

From: Assessing the impact of the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) on hospital antimicrobial stewardship programmes: results of a worldwide survey

 

n (%)

High-income countries (n = 76)

Low- and middle-income countries (n = 156)

Total (n = 232)

P-value† (α = 0.0036)

Optimising therapeutic antimicrobial use

43 (56.6)

105 (67.3)

148 (63.8)

0.147

Optimising surgical prophylaxis

38 (50.0)

91 (58.3)

129 (55.6)

0.290

Translating PPS results into AMS interventions

38 (50.0)

71 (45.5)

109 (47.0)

0.615

Communicating with prescribers

35 (46.1)

61 (39.1)

96 (41.4)

0.386

Managing difficult-to-treat MDRO infections*

25 (32.9)

71 (45.5)

96 (41.4)

0.091

Identifying the low-hanging fruit for AMS in the hospital

38 (50.0)

56 (35.9)

94 (40.5)

0.056

Translating PPS results into IPC** interventions

17 (22.4)

61 (39.1)

78 (33.6)

0.017

Formulating/revising guidelines

21 (27.6)

54 (34.6)

75 (32.3)

0.359

Performing audit and feedback

17 (22.4)

54 (34.6)

71 (30.6)

0.081

Understanding antimicrobial susceptibility data

15 (19.7)

55 (35.3)

70 (30.2)

0.024

How to create an active stewardship committee/team

9 (11.8)

41 (26.3)

50 (21.6)

0.019

How to communicate with patients on antimicrobial use

13 (17.1)

28 (18.0)

41 (17.7)

1.000

Other learning needs

1 (1.3)

2 (1.3)

3 (1.3)

1.000

None

2 (2.6)

0 (0.0)

2 (0.9)

0.106

  1. *MDRO: multi-drug resistant organisms; **IPC: infection prevention and control †Statistical significance evaluated using the Pearson’s chi-squared test or Fisher’s exact test. Significance level (α) has been corrected for multiple testing